171 related articles for article (PubMed ID: 37537683)
1. The impact of bleeding event frequency on health-related quality of life and work productivity outcomes in a European cohort of adults with haemophilia A: insights from the CHESS II study.
Young L; Chen Y; Alvir J; Burke T; Ferri Grazzi E; Winburn I
Orphanet J Rare Dis; 2023 Aug; 18(1):227. PubMed ID: 37537683
[TBL] [Abstract][Full Text] [Related]
2. Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B.
Burke T; Shaikh A; Ali TM; Li N; Curtis R; Garcia Diego DA; Recht M; Sannie T; Skinner M; O'Hara J
J Med Econ; 2022; 25(1):386-392. PubMed ID: 35253589
[TBL] [Abstract][Full Text] [Related]
3. Social/economic costs and quality of life in patients with haemophilia in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study.
Rodriguez-Santana I; DasMahapatra P; Burke T; Hakimi Z; Bartelt-Hofer J; Nazir J; O'Hara J
Orphanet J Rare Dis; 2022 Apr; 17(1):150. PubMed ID: 35379284
[TBL] [Abstract][Full Text] [Related]
5. Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.
Burke T; Asghar S; O'Hara J; Chuang M; Sawyer EK; Li N
Orphanet J Rare Dis; 2021 Dec; 16(1):521. PubMed ID: 34930388
[TBL] [Abstract][Full Text] [Related]
6. Humanistic burden of problem joints for children and adults with haemophilia.
Burke T; Rodriguez-Santana I; Chowdary P; Curtis R; Khair K; Laffan M; Mclaughlin P; Noone D; O'Mahony B; Pasi J; Skinner M; O'Hara J
Haemophilia; 2023 Mar; 29(2):608-618. PubMed ID: 36574369
[TBL] [Abstract][Full Text] [Related]
7. Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.
Booth J; Oladapo A; Walsh S; O'Hara J; Carroll L; Garcia Diego DA; O'Mahony B
Haemophilia; 2018 Sep; 24(5):e322-e327. PubMed ID: 30091822
[TBL] [Abstract][Full Text] [Related]
8. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.
O'Hara J; Walsh S; Camp C; Mazza G; Carroll L; Hoxer C; Wilkinson L
Health Qual Life Outcomes; 2018 May; 16(1):84. PubMed ID: 29720192
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).
Mahlangu J; Oldenburg J; Callaghan MU; Shima M; Mancuso ME; Trask P; Recht M; Garcia C; Yang R; Lehle M; Macharia H; Asikanius E; Levy GG; Kruse-Jarres R; von Mackensen S
Haemophilia; 2019 May; 25(3):382-391. PubMed ID: 31016855
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.
Oldenburg J; Tran H; Peyvandi F; Núñez R; Trask P; Chebon S; Mahlangu JN; Lehle M; Jiménez-Yuste V; von Mackensen S
Haemophilia; 2021 May; 27(3):398-407. PubMed ID: 33576546
[TBL] [Abstract][Full Text] [Related]
11. Differential humanistic and economic burden of mild, moderate and severe haemophilia in european adults: a regression analysis of the CHESS II study.
Rodriguez-Santana I; DasMahapatra P; Burke T; Hakimi Z; Bartelt-Hofer J; Nazir J; O'Hara J
Orphanet J Rare Dis; 2022 Apr; 17(1):148. PubMed ID: 35379282
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
[TBL] [Abstract][Full Text] [Related]
13. The humanistic and economic burden of problem joints for children and adults with moderate or severe haemophilia A: Analysis of the CHESS population studies.
Chowdary P; Nissen F; Burke T; Aizenas M; Czirok T; Dhillon H; O'Hara J
Haemophilia; 2023 May; 29(3):753-760. PubMed ID: 36897517
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life of patients with haemophilia: a cross-sectional survey in the Northeast of China.
Niu J; Ning L; Zhang Q; Liu Z; Ma Y; Xu X; Wu Q; Hao Y; Cui Y; Liu C
BMJ Open; 2022 Feb; 12(2):e056668. PubMed ID: 35105597
[TBL] [Abstract][Full Text] [Related]
15. The cost of severe haemophilia in Europe: the CHESS study.
O'Hara J; Hughes D; Camp C; Burke T; Carroll L; Diego DG
Orphanet J Rare Dis; 2017 May; 12(1):106. PubMed ID: 28569181
[TBL] [Abstract][Full Text] [Related]
16. Clinical attributes and treatment characteristics are associated with work productivity and activity impairment in people with severe haemophilia A.
O'Hara J; Noone D; Jain M; Pedra G; Landis S; Hawes C; Burke T; Camp C
Haemophilia; 2021 Nov; 27(6):938-946. PubMed ID: 34273215
[TBL] [Abstract][Full Text] [Related]
17. Burden of rheumatoid arthritis on patients' work productivity and quality of life.
Xavier RM; Zerbini CAF; Pollak DF; Morales-Torres JLA; Chalem P; Restrepo JFM; Duhau JA; Amado JR; Abello M; de la Vega MC; Dávila AP; Biegun PM; Arruda MS; Ramos-Remus C
Adv Rheumatol; 2019 Nov; 59(1):47. PubMed ID: 31706348
[TBL] [Abstract][Full Text] [Related]
18. Anxiety and depression among adults with haemophilia A: Patient and physician reported symptoms from the real-world European CHESS II study.
Ferri Grazzi E; Blenkiron T; Hawes C; Camp C; O'Hara J; Burke T; O'Brien G
Haemophilia; 2024 May; 30(3):743-751. PubMed ID: 38507035
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life of moderate and severe haemophilia patients: Results of the haemophilia-specific quality of life index in Korea.
Baek HJ; Park YS; Yoo KY; Cha JH; Kim YJ; Lee KS
PLoS One; 2020; 15(9):e0238686. PubMed ID: 32881977
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1.
O'Mahony B; Dunn AL; Leavitt AD; Peyvandi F; Ozelo MC; Mahlangu J; Peerlinck K; Wang JD; Lowe GC; Tan CW; Giermasz A; Tran H; Khoo TL; Cockrell E; Pepperell D; Chambost H; López Fernández MF; Kazmi R; Majerus E; Skinner MW; Klamroth R; Quinn J; Yu H; Wong WY; Robinson TM; Pipe SW
J Thromb Haemost; 2023 Dec; 21(12):3450-3462. PubMed ID: 37678546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
